Volume 3: Issue 11-12
pp297-350
About the CoverThe cover for this issue of Oncoscience features Figure 4 ("Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development") from Marquez-Vilendrer et al. |
Editorials
Bevacizumab in HER2-negative inflammatory breast cancer
https://doi.org/10.18632/oncoscience.324
François Bertucci, Anthony Goncalves, Patrice Viens
p 297-298
Gene enhancer deregulation and epigenetic vulnerability
https://doi.org/10.18632/oncoscience.334
Rui Lu, Gang Greg Wang
p 299-301
Adaptive survival mechanism to glucose restrictions
https://doi.org/10.18632/oncoscience.332
Nabil Djouder
p 302-303
Breast-conserving therapy versus mastectomy
https://doi.org/10.18632/oncoscience.331
Marissa C. van Maaren, Philip Poortmans, Sabine Siesling
p 304-305
Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death
https://doi.org/10.18632/oncoscience.330
Michaël Cerezo, Rachid Benhida, Stéphane Rocchi
p 306-307
A miRNA signature assessing ovarian cancer prognosis
https://doi.org/10.18632/oncoscience.329
Marina Bagnoli, Sandro Pignata, Delia Mezzanzanica
p 308-310
Genetic biomarkers for PD-1/PD-L1 blockade therapy
https://doi.org/10.18632/oncoscience.328
Keisuke Kataoka, Seishi Ogawa
p 311-312
Eradication of CML stem cells
https://doi.org/10.18632/oncoscience.327
Bing Z. Carter, Michael Andreeff
p 313-315
BET bromodomain inhibitor (JQ1) and tumor angiogenesis
https://doi.org/10.18632/oncoscience.326
Hemant Kumar Bid, Samuel Kerk
p 316-317
Mutation hotspots in cis-regulatory regions in cancer
https://doi.org/10.18632/oncoscience.325
Rebecca C. Poulos, Jason W. H. Wong
p 318-319
CD44: A metastasis driver and therapeutic target
https://doi.org/10.18632/oncoscience.335
Joseph K. Sottnik, Dan Theodorescu
p 320-321
Research Papers
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development
https://doi.org/10.18632/oncoscience.323
Stefanie B. Marquez-Vilendrer, Sudhir K. Rai, Sarah JB Gramling, Li Lu, David N. Reisman
p 322-336
Abstract | PDF | Full Text | Supplementary Material 1 | Supplementary Material 2 | How to Cite
BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo
https://doi.org/10.18632/oncoscience.333
Stefanie B. Marquez-Vilendrer, Sudhir K. Rai, Sarah JB Gramling, Li Lu, David N. Reisman
p 337-350
Abstract | PDF | Full Text | Supplementary Material | How to Cite